Dopamine D2/D3 and serotonin 5-HT1A receptor drugs for Major Depressive Disorder

2 tracked Dopamine D2/D3 and serotonin 5-HT1A receptor drugs in the Major Depressive Disorder race. The class explanation lives on the Dopamine D2/D3 and serotonin 5-HT1A receptor page; the full indication pipeline across every mechanism is on the Major Depressive Disorder page.

2 approved / phase 4

Head-to-head evidence: Aripiprazole (Abilify) vs Brexpiprazole (Rexulti)

The roster

← all Dopamine D2/D3 and serotonin 5-HT1A receptor drugs